{"title":"更智能的治疗方案解决肥胖和阻塞性睡眠呼吸暂停(OSA)的无声威胁","authors":"","doi":"10.47485/2693-2458/1003","DOIUrl":null,"url":null,"abstract":"Obesity is a rapidly growing global public health issue in view of its prevalence, costs, and complications. As per WHO in 2016, the worldwide prevalence of obesity (BMI>30Kg/m2) is about 13% of the world’s adult population (11% of men and 15% of women). The worldwide prevalence of obesity nearly tripled between 1975 and 2016. 29% of adults were classified as obese in England 2019, an increase from 26% in 2016 [1].","PeriodicalId":424815,"journal":{"name":"Journal of Diabetes and Endocrinology Research","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Smarter treatment options to tackle the silent menace of Obesity and Obstructive Sleep Apnoea (OSA)\",\"authors\":\"\",\"doi\":\"10.47485/2693-2458/1003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Obesity is a rapidly growing global public health issue in view of its prevalence, costs, and complications. As per WHO in 2016, the worldwide prevalence of obesity (BMI>30Kg/m2) is about 13% of the world’s adult population (11% of men and 15% of women). The worldwide prevalence of obesity nearly tripled between 1975 and 2016. 29% of adults were classified as obese in England 2019, an increase from 26% in 2016 [1].\",\"PeriodicalId\":424815,\"journal\":{\"name\":\"Journal of Diabetes and Endocrinology Research\",\"volume\":\"31 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Diabetes and Endocrinology Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47485/2693-2458/1003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes and Endocrinology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47485/2693-2458/1003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Smarter treatment options to tackle the silent menace of Obesity and Obstructive Sleep Apnoea (OSA)
Obesity is a rapidly growing global public health issue in view of its prevalence, costs, and complications. As per WHO in 2016, the worldwide prevalence of obesity (BMI>30Kg/m2) is about 13% of the world’s adult population (11% of men and 15% of women). The worldwide prevalence of obesity nearly tripled between 1975 and 2016. 29% of adults were classified as obese in England 2019, an increase from 26% in 2016 [1].